The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study
Hua Shen(Jiangsu Province Hospital), Yongqian Shu(Jiangsu Province Hospital), Changping Wu(Soochow University), Rongsheng Wang(University of Science and Technology of China), Yongmei Yin(Nanjing Medical University), Xiaodong Li(Fujian Medical University)
Cited by 36
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
|Cancer Cell|2021|232
Magnetic Reconnection in the Near Venusian Magnetotail
|Science|2012|166